140 related articles for article (PubMed ID: 833737)
1. Separation and analysis of delta 9-tetrahydrocannabinol in biological fluids by high-pressure liquid chromatography and GLC.
Garrett ER; Hunt CA
J Pharm Sci; 1977 Jan; 66(1):20-6. PubMed ID: 833737
[TBL] [Abstract][Full Text] [Related]
2. Separation and sensitive assay of THC in biological fluids by HPLC and GLC.
Garrett ER; Hunt CA
NIDA Res Monogr; 1976 May; (7):33-41. PubMed ID: 967239
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
[TBL] [Abstract][Full Text] [Related]
4. Combined high-pressure liquid chromatography and radioimmunoassay method for the quantitation of delta 9-tetrahydrocannabinol and some of its metabolites in human plasma.
Williams PL; Moffat AC; King LJ
J Chromatogr; 1978 Aug; 155(2):273-83. PubMed ID: 681490
[TBL] [Abstract][Full Text] [Related]
5. Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ(9)-tetrahydrocannabinol in rat plasma.
Zgair A; Wong JC; Sabri A; Fischer PM; Barrett DA; Constantinescu CS; Gershkovich P
J Pharm Biomed Anal; 2015 Oct; 114():145-51. PubMed ID: 26048666
[TBL] [Abstract][Full Text] [Related]
6. The separation, identification, and quantitation of cannabinoids and their tau=butyldimethylsilyl, trimethylsilylacetate, and diethylphosphate derivatives using high-pressure liquid chromatography, gas-liquid chromatography, and mass spectrometry.
Knaus EE; Coutts RT; Kazakoff CW
J Chromatogr Sci; 1976 Nov; 14(11):525-30. PubMed ID: 977713
[TBL] [Abstract][Full Text] [Related]
7. delta 9-Tetrahydrocannabinol by GLC-MS validated radioimmunoassays of hemolyzed blood or serum.
Yeager EP; Goebelsmann U; Soares JR; Grant JD; Gross SJ
J Anal Toxicol; 1981; 5(2):81-4. PubMed ID: 6264224
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
Nakahara Y; Sekine H; Cook CE
J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
[TBL] [Abstract][Full Text] [Related]
9. Combination of liquid chromatography with ultraviolet detection and gas chromatography with electron-capture detection for the determination of delta 9-tetrahydrocannabinol-11-oic acid in urine.
Karlsson L; Roos C
J Chromatogr; 1984 Mar; 306():183-9. PubMed ID: 6325483
[TBL] [Abstract][Full Text] [Related]
10. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
[TBL] [Abstract][Full Text] [Related]
11. Ultra-high performance liquid chromatography tandem mass-spectrometry for simple and simultaneous quantification of cannabinoids.
Jamwal R; Topletz AR; Ramratnam B; Akhlaghi F
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():10-18. PubMed ID: 28192758
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine II. A HPLC procedure.
ElSohly MA; ElSohly HN; Jones AB; Dimson PA; Wells KE
J Anal Toxicol; 1983; 7(6):262-4. PubMed ID: 6319818
[TBL] [Abstract][Full Text] [Related]
13. The detection of Delta9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry.
Scurlock RD; Ohlson GB; Worthen DK
J Anal Toxicol; 2006 May; 30(4):262-6. PubMed ID: 16803665
[TBL] [Abstract][Full Text] [Related]
14. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry.
Shaw LM; Edling-Owens J; Mattes R
Clin Chem; 1991 Dec; 37(12):2062-8. PubMed ID: 1662560
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry.
Maralikova B; Weinmann W
J Mass Spectrom; 2004 May; 39(5):526-31. PubMed ID: 15170748
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the analysis of delta 9-tetrahydrocannabinol capsules by high-performance liquid chromatography and capillary gas chromatography.
Ray G; Crook M; West N; Kwoka M; Rehagen G; Cox J; Murrill E; Flora K
J Chromatogr; 1984 Dec; 317():455-62. PubMed ID: 6099368
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment of urine samples for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using solid-phase extraction.
Parry RC; Nolan L; Shirey RE; Wachob GD; Gisch DJ
J Anal Toxicol; 1990; 14(1):39-44. PubMed ID: 2156110
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples.
Valiveti S; Stinchcomb AL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):243-8. PubMed ID: 15063332
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
